201 related articles for article (PubMed ID: 17313422)
21. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
Kuo HC
Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
[TBL] [Abstract][Full Text] [Related]
22. Editorial comment on: Intraprostatic and bladder-neck botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
Michel M
Eur Urol; 2008 Mar; 53(3):626-7. PubMed ID: 17950523
[No Abstract] [Full Text] [Related]
23. Intradetrusor botulinum toxin injections for neurogenic overactive bladder: are we there yet?
Lemack GE
Eur Urol; 2008 Feb; 53(2):240-1. PubMed ID: 17997019
[No Abstract] [Full Text] [Related]
24. Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.
Sahai A; Khan MS; Le Gall N; Dasgupta P;
Urology; 2008 Mar; 71(3):455-9. PubMed ID: 18342186
[TBL] [Abstract][Full Text] [Related]
25. Editorial comment on: Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
Pickard R
Eur Urol; 2008 Mar; 53(3):626. PubMed ID: 17950524
[No Abstract] [Full Text] [Related]
26. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
Kulaksizoglu H; Parman Y
Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety of botulinum toxin type A.
Naumann M; Moore AP
Mov Disord; 2003 Sep; 18(9):1080-1. PubMed ID: 14502686
[No Abstract] [Full Text] [Related]
28. Re: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Cartwright R; Cardozo L
J Urol; 2007 Feb; 177(2):796-7; author reply 797. PubMed ID: 17222687
[No Abstract] [Full Text] [Related]
29. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
Mazo EB; Krivoborodov GG; Efremov NS
Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
[TBL] [Abstract][Full Text] [Related]
30. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
31. Refractory neurogenic detrusor overactivity.
Cruz F; Silva C
Int J Clin Pract Suppl; 2006 Dec; (151):22-6. PubMed ID: 17169007
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
Sahai A; Khan MS; Gregson N; Smith K; Dasgupta P;
Nat Clin Pract Urol; 2007 Jul; 4(7):379-86. PubMed ID: 17615549
[TBL] [Abstract][Full Text] [Related]
33. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
34. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
Haferkamp A
Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
[No Abstract] [Full Text] [Related]
35. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms.
Cruz F; Dinis P
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):920-7. PubMed ID: 17705161
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin in the treatment of OAB, BPH, and IC.
Smith CP
Toxicon; 2009 Oct; 54(5):639-46. PubMed ID: 19268490
[TBL] [Abstract][Full Text] [Related]
37. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
Del Popolo G; Filocamo MT; Li Marzi V; Macchiarella A; Cecconi F; Lombardi G; Nicita G
Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
[TBL] [Abstract][Full Text] [Related]
38. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
Scheinberg A; O'Flaherty S; Waugh MC; Baxter A; Gurd K
J Paediatr Child Health; 2008; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
[No Abstract] [Full Text] [Related]
39. Safety of botulinum neurotoxin treatment in patients with chronic anal fissure.
Brisinda D; Maria G; Fenici R; Civello IM; Brisinda G
Dis Colon Rectum; 2003 Mar; 46(3):419-20. PubMed ID: 12626924
[No Abstract] [Full Text] [Related]
40. BOTOX for headache treatment.
Rothrock JF
Headache; 2007 Feb; 47(2):345-6. PubMed ID: 17300388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
